Why the study?
Digital health technologies like mHealth and wearables are rapidly transforming cardiovascular disease prevention, but challenges including ethical, regulatory, and accessibility issues need examination before widespread adoption.
Population
English articles from 2015 to 2025 and an article from 2002 indexed in Scopus, PubMed, and Google Scholar
Design
Review
Authors
Loading...
May aid remote AF detection and self-care now but should not yet change practice; leaves open outcome trials and equity solutions.
mHealth and wearable devices offer significant potential for cardiovascular disease prevention through continuous monitoring and early detection, though ethical, regulatory, and accessibility challenges remain.
Ahmad et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: